For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
As of close of business last night, Axsome Therapeutics Inc’s stock clocked out at $126.41, down -1.50% from its previous closing price of $128.33. In other words, the price has decreased by -$1.50 from its previous closing price. On the day, 0.59 million shares were traded.
Ratios:
To gain a deeper understanding of AXSM’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.04 and its Current Ratio is at 2.11. In the meantime, Its Debt-to-Equity ratio is 3.56 whereas as Long-Term Debt/Eq ratio is at 3.33.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Deutsche Bank on February 11, 2025, initiated with a Buy rating and assigned the stock a target price of $176.
On December 31, 2024, Mizuho reiterated its Outperform rating and also upped its target price recommendation from $124 to $122.
On September 03, 2024, Wells Fargo started tracking the stock assigning a Overweight rating and target price of $140.Wells Fargo initiated its Overweight rating on September 03, 2024, with a $140 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Feb 13 ’25 when Pizzie Nick sold 12,000 shares for $129.86 per share. The transaction valued at 1,558,320 led to the insider holds 42,187 shares of the business.
Pizzie Nick sold 3,000 shares of AXSM for $393,210 on Feb 14 ’25. The Chief Financial Officer now owns 42,187 shares after completing the transaction at $131.07 per share. On Feb 14 ’25, another insider, Pizzie Nick, who serves as the Officer of the company, bought 3,000 shares for $131.07 each.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 15.98 while its Price-to-Book (P/B) ratio in mrq is 107.90.
Stock Price History:
Over the past 52 weeks, AXSM has reached a high of $139.13, while it has fallen to a 52-week low of $64.11. The 50-Day Moving Average of the stock is 21.79%, while the 200-Day Moving Average is calculated to be 39.18%.
Shares Statistics:
A total of 48.67M shares are outstanding, with a floating share count of 40.02M. Insiders hold about 17.93% of the company’s shares, while institutions hold 77.75% stake in the company.
